ClinicalTrials.Veeva

Menu

The Effect of Breakfast With Different Macronutrient Composition on PYY, Ghrelin, GLP-1,Glucose Level, VAS for Hunger, VAS for Satiety and Ad Libitum Intake 4 Hours After Breakfast in Obese Women

U

University of Indonesia (UI)

Status

Completed

Conditions

Protein Consumption
Ghrelin
Gut Hormones
Obesity
PYY
Appetite

Treatments

Behavioral: diet with different composition

Study type

Interventional

Funder types

Other

Identifiers

NCT03697486
GuthormonesS3

Details and patient eligibility

About

Gut hormones, such as PYY and ghrelin, are associated with appetite control and obesity. Protein is thought to be the most satieting nutrient and could affect production of several gut hormones. This study's objective is to find the effect of breakfast with different protein composition on PYY, ghrelin, and ad libitum intake four hours after breakfast.

The research methodology was used a clinical trial with 22 obese women participants. Subjects were given three types of breakfast: low protein consumption (12.4% protein), medium protein (23.5% protein), and high protein (40,6% protein). PYY and ghrelin level were measured at 0, 15, 60, 120, and 180 minutes after breakfast. Ad libitum meal was given four hours after breakfast and measured after.

Enrollment

22 patients

Sex

Female

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • BMI 25-30 (obese)
  • with stable body weight within the last 6 months (body weight change less than 4 kg)
  • normal blood glucose level.

Exclusion criteria

  • patients who never had breakfast
  • patients in weight loss program
  • patients consuming lipid-absorption inhibitor or appetite-suppressing drugs
  • patients that have had gastrointestinal tract resection.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

22 participants in 3 patient groups

High Protein
Experimental group
Description:
(40,6% protein)
Treatment:
Behavioral: diet with different composition
Moderate Protein
Experimental group
Description:
(23.5% protein)
Treatment:
Behavioral: diet with different composition
Low Protein
Experimental group
Description:
(12.4% protein)
Treatment:
Behavioral: diet with different composition

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems